2.32

3.73% -0.09

Heron Therapeutics Inc (HRTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HRTX? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.41

Offen:

$2.4

24-Stunden-Volumen:

1.03M

Relative Volume:

0.50

Marktkapitalisierung:

$353.40M

Einnahmen:

$137.74M

Nettoeinkommen (Verlust:

$-27.97M

KGV:

-14.50

EPS:

-0.16

Netto-Cashflow:

$-9.61M

1W Leistung:

-1.69%

1M Leistung:

+40.61%

6M Leistung:

+24.06%

1J Leistung:

-22.92%

1-Tages-Spanne:

$2.25

$2.42

1-Wochen-Bereich:

$2.12

$2.45

52-Wochen-Spanne:

$1.04

$3.93

Heron Therapeutics Inc Stock (HRTX) Company Profile

Firmenname

Heron Therapeutics Inc

Sektor

Healthcare (1169)

Branche

Biotechnology (679)

Telefon

(858) 251-4400

Adresse

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

Mitarbeiter

122

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

HRTX's Discussions on Twitter

Vergleichen Sie HRTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HRTX Heron Therapeutics Inc	2.32	353.40M	137.74M	-27.97M	-9.61M	-0.16
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-13	Eingeleitet	Rodman & Renshaw	Buy
2024-04-23	Eingeleitet	CapitalOne	Overweight
2024-03-13	Bestätigt	Needham	Buy
2020-05-27	Eingeleitet	Guggenheim	Buy
2020-02-20	Bestätigt	Needham	Buy
2019-01-16	Bestätigt	Needham	Buy
2018-04-05	Eingeleitet	Evercore ISI	Outperform
2018-03-19	Bestätigt	Mizuho	Buy
2018-03-01	Bestätigt	Needham	Buy
2018-01-03	Eingeleitet	Leerink Partners	Outperform
2017-09-27	Eingeleitet	Northland Capital	Outperform
2017-02-27	Eingeleitet	Needham	Buy
2016-10-26	Eingeleitet	Aegis Capital	Buy
2016-09-06	Fortgesetzt	Lake Street	Buy
2016-05-03	Eingeleitet	Cantor Fitzgerald	Buy
2015-12-10	Eingeleitet	Lake Street	Buy
2015-09-23	Bestätigt	Leerink Partners	Outperform
2015-09-02	Eingeleitet	BofA/Merrill	Buy
2015-08-03	Bestätigt	Brean Capital	Buy
2015-06-30	Bestätigt	JMP Securities	Mkt Outperform
2015-06-19	Bestätigt	Leerink Partners	Outperform
2014-08-07	Eingeleitet	Noble Financial	Buy

Alle ansehen

Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten

Mar 12, 2025

Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Mar 12, 2025

CM Management LLC Purchases 200,000 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Mar 12, 2025

Mar 11, 2025

StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat

Mar 11, 2025

Why Heron Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register

Mar 11, 2025

Mar 09, 2025

Los Angeles Capital Management LLC Sells 153,181 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat

Mar 09, 2025

Principal Financial Group Inc. Raises Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World

Mar 09, 2025

Heron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday - Defense World

Mar 09, 2025

Mar 08, 2025

Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha

Mar 08, 2025

Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World

Mar 08, 2025

Mar 07, 2025

Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat

Mar 04, 2025

Heron Therapeutics (NASDAQ:HRTX) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Mar 04, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - MarketBeat

Mar 04, 2025

Mar 03, 2025

Heron Therapeutics (NASDAQ:HRTX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Mar 03, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - accessnewswire.com

Mar 03, 2025

Brokers Offer Predictions for HRTX Q1 Earnings - Defense World

Mar 03, 2025

Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Mar 03, 2025

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Mar 02, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by New York State Common Retirement Fund - Defense World

Mar 02, 2025

Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 02, 2025

Mar 01, 2025

Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Shares Bounce 48% But Its Business Still Trails The Industry - Simply Wall St

Mar 01, 2025

Feb 28, 2025

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

High Growth Tech Stocks to Watch in US Market February 2025 - Yahoo Finance

Feb 28, 2025

Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years - Simply Wall St

Feb 28, 2025